Novartis Investigative Site

Campinas 13092-133

0 studies enrolling now · 5 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Chronic Myeloid Leukemia, Leukemia, Myeloid, Chronic Phase, Primary Prevention of Atherosclerotic Cardiovascular Disease, Transfusional Iron Overload in β-thalassemia

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) — Stopped early
• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE
• An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload — Completed